Back
Vanguard FTSE Dev All Cap ex US ETF CADH Vs. Aligos Therapeutics Industry Stock Comparison
Buy
75
VEF.TO
Vanguard FTSE Dev All Cap ex US ETF CADH
Last Price:
57.92
Seasonality Move:
2.22%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Buy
75
Vanguard FTSE Dev All Cap ex US ETF CADH (VEF.TO)
is a Buy
Is Vanguard FTSE Dev All Cap ex US ETF CADH a Buy, Sell or Hold?
- The current Vanguard FTSE Dev All Cap ex US ETF CADH [VEF.TO] share price is $57.92. The Score for VEF.TO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- VEF.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VEF.TO Stock Price Chart
What is Vanguard FTSE Dev All Cap ex US ETF CADH's stock price today?
-
The Vanguard FTSE Dev All Cap ex US ETF CADH share price today is $57.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VEF.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
VEF.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 64.57 | Buy |
| Chaikin Money Flow: | 7970 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.33 - 57.45) | Buy |
| Bollinger Bands (100): | (55.4 - 57.34) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.71 | Buy |
| Relative Strength Index (14 RSI): | 85.17 | Buy |
| Chaikin Money Flow: | 491004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.08 - 27.66) | Buy |
| Bollinger Bands (100): | (7.67 - 19.61) | Buy |
VEF.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.6 | Buy |
| 20-day SMA: | 56.96 | Buy |
| 50-day SMA: | 56.91 | Buy |
| 200-day SMA: | 56.15 | Buy |
| 8-day EMA: | 57.53 | Buy |
| 20-day EMA: | 57.17 | Buy |
| 50-day EMA: | 56.86 | Buy |
| 200-day EMA: | 55.56 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.48 | Buy |
| 20-day SMA: | 23.64 | Buy |
| 50-day SMA: | 14.76 | Buy |
| 200-day SMA: | 15.86 | Buy |
| 8-day EMA: | 28.77 | Buy |
| 20-day EMA: | 23.99 | Buy |
| 50-day EMA: | 18.16 | Buy |
| 200-day EMA: | 16.13 | Buy |
Vanguard FTSE Dev All Cap ex US ETF CADH Earnings Growth & VEF.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Vanguard FTSE Dev All Cap ex US ETF CADH Technical Analysis
| Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||